Abstract
ABSTRACT Robenacoxib is a selective non-steroidal anti-inflammatory drug indicated for pain control in felines. The objective was to evaluate the effect of robenacoxib on the minimum alveolar concentration of isoflurane in cats. There were 30 cats that used one of the 3 treatments through therapy: GM - meloxicam (0.2 mg/kg), GR - robenacoxib (2 mg/kg) or GC - 0.9% saline solution (0.1 ml/kg) kg). We waited 30 minutes, and the animals were induced to general anesthesia with isoflurane in an induction box, intubated and anesthetized with 1.5 V% isoflurane. All animals were secured to a supramaximal nociceptive stimulus (tail pinch). Positive response was defined as proposed movement of the head and/or limbs. The method for determining MAC was up and down to Dixon, and calculation of the average of crossover values according to Monteiro (2016). The mean and standard deviation of ISOMAC was 2.10±0.15%, 1.95±0.14%, and 1.7±0.15% in GC, GM, and GR, respectively. Robenacoxib reduced to 19.1% and 12.8% ISOMAC when compared to a control group and a group that received meloxicam, respectively.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
